Sfoglia per AUTORE
KIM SY
Collezione AOU Novara
Items : 2
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1?50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. in Journal for immunotherapy of cancer / J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674.
2025
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer. in Cancer treatment reviews / Cancer Treat Rev. 2020 Jun;86:102020. doi: 10.1016/j.ctrv.2020.102020. Epub 2020 Apr 4.
2020
AOU Novara
AOU Novara
Khan K; Cascinu S; Cunningham D; Kim SY; Oki E; Seery T; Shen L; Siena S; Tournigand C; Turhal NS; Hendlisz A;